| Autor: |
Perez, Nikki, Dasmahapatra, Amita, Khalid, Mona, Aubert, Ronald E. |
| Předmět: |
|
| Zdroj: |
Diabetes; Jun2007 Supplement 1, Vol. 56, pA245-A245, 1/6p |
| Abstrakt: |
The objective of this study is to estimate differences in the prevalence of pharmacologically treated type 2 diabetes in children by age and sex. The study measured the prevalence of treated type 2 diabetes in 2005 using pharmacy claims data from a population of commercially-insured Americans. The sample included 575,070 children aged 0 to 19. Type 2 diabetes was identified as a prescription for an oral diabetes agent, with or without insulin. Children 12 to 19 had the highest prevalence of type 2 diabetes (192.4 per 100,000 children). The lowest prevalence of diabetes was in children 0 to 5 years old (9.14 per 100,000). This represents a 21 fold increased risk of diabets in children aged 12 to 19 when compared with children aged 0 to 5. Girls were 3.3 times more likely to have type 2 diabetes than boys (CI 2.75 - 4.02). Girls aged 12 to 19 had the highest prevalence of any age group (303.3 per 100,000); 3.6 times (CI 2.9 - 4.3) higher than boys of the same age (85.3 per 100,000). In children under 12, girls had a greater prevalence of type 2 diabetes compared to boys (29.8 per 100,000 vs. 12.0 per 100,000) but to a lesser extent than children 12 to 19. Children aged 12 to 19 had the highest prevalence of treated type 2 diabetes. Girls of any age had a higher prevalence than their male counterparts. Given the increase in obesity, type 2 diabetes in children may continue to increase, escalating the economic burden due to earlier onset. The longer duration of disease may increase the potential for complications later in life. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
